Michael Secora
Chief Financial Officer at Recursion Pharmaceuticals, Inc. (RXRX)
Michael Secora has filed 31 insider reports with the SEC since April 2021, as chief Financial Officer at Recursion Pharmaceuticals, Inc. (RXRX). Michael Secora made no open-market purchases or sales in the last 12 months. The latest filing, on November 19, 2024, reports shares withheld for taxes or exercise price at Recursion Pharmaceuticals, Inc. (RXRX).
- Filings
- 31
- Companies
- 1
- Bought on market
- None
- Sold on market
- $6.4M
Companies where Michael Secora is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | 1,487,694 | $6.4M | $2.905 | Nov 19, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 15, 2024RXRXChief Financial Officer Secora Michael covered exercise/tax liability with 11,937 shares, decreasing direct ownership by 0.80% to 1,487,694 unitsForm 4Shares withheld for taxes or exercise price
- Nov 13, 2024-$230KRXRXChief Financial Officer Secora Michael exercised 78,750 shares at a strike of $2.22 and sold $229,504 worth of shares (30,000 units at $7.65), increasing direct ownership by 3% to 1,499,631 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 9, 2024-$190KRXRXChief Financial Officer Secora Michael exercised 78,750 shares at a strike of $2.22 and sold $190,131 worth of shares (30,000 units at $6.34), increasing direct ownership by 3% to 1,450,881 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 11, 2024-$187KRXRXChief Financial Officer Secora Michael exercised 78,750 shares at a strike of $2.22 and sold $187,228 worth of shares (30,000 units at $6.24), increasing direct ownership by 4% to 1,402,131 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 15, 2024RXRXChief Financial Officer Secora Michael covered exercise/tax liability with 11,962 shares, decreasing direct ownership by 0.88% to 1,353,381 unitsForm 4Shares withheld for taxes or exercise price
- Aug 14, 2024-$190KRXRXChief Financial Officer Secora Michael sold $190,434 worth of shares (30,000 units at $6.35) and exercised 78,750 shares at a strike of $2.22, increasing direct ownership by 4% to 1,365,343 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 10, 2024-$218KRXRXChief Financial Officer Secora Michael sold $218,354 worth of shares (30,000 units at $7.28) and exercised 78,750 shares at a strike of $2.22, increasing direct ownership by 4% to 1,316,593 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 14, 2024-$279KRXRXChief Financial Officer Secora Michael exercised 78,750 shares at a strike of $2.22 and sold $278,880 worth of shares (30,000 units at $9.30), increasing direct ownership by 4% to 1,267,843 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 15, 2024RXRXSecora Michael covered exercise/tax liability with 11,962 shares, decreasing direct ownership by 0.97% to 1,219,093 unitsForm 4Shares withheld for taxes or exercise price
- Apr 17, 2024-$367KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $367,007 worth of shares (48,124 units at $7.63), increasing direct ownership by 2% to 1,231,055 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 13, 2024-$537KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $537,190 worth of shares (50,000 units at $10.74), increasing direct ownership by 2% to 1,204,179 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 15, 2024RXRXSecora Michael covered exercise/tax liability with 7,172 shares, decreasing direct ownership by 0.60% to 1,179,179 unitsForm 4Shares withheld for taxes or exercise price
- Feb 14, 2024-$508KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $507,985 worth of shares (50,000 units at $10.16), increasing direct ownership by 2% to 1,186,351 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 9, 2024RXRXSecora Michael was granted 182,849 shares and covered exercise/tax liability with 2,512 shares, increasing direct ownership by 18% to 1,161,351 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jan 17, 2024-$518KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $517,508 worth of shares (50,000 units at $10.35), increasing direct ownership by 3% to 981,014 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 13, 2023-$375KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $374,638 worth of shares (50,000 units at $7.49), increasing direct ownership by 3% to 956,014 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 15, 2023-$341KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22, sold $340,929 worth of shares (50,000 units at $6.82) and covered exercise/tax liability with 7,172 shares, increasing direct ownership by 2% to 931,014 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 11, 2023-$348KRXRXSecora Michael exercised 75,000 shares at a strike of $2.22 and sold $348,075 worth of shares (50,000 units at $6.96), increasing direct ownership by 3% to 913,186 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 13, 2023-$428KRXRXSEC Form 4: Secora Michael exercised 75,000 shares at a strike of $2.22 and sold $427,950 worth of shares (50,000 units at $8.56), increasing direct ownership by 3% to 888,186 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 16, 2023-$454KRXRXSEC Form 4: Secora Michael covered exercise/tax liability with 4,727 shares, exercised 75,000 shares at a strike of $2.22 and sold $454,310 worth of shares (50,000 units at $9.09), increasing direct ownership by 2% to 863,186 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 19, 2023-$729KRXRXSEC Form 4 filed by Secora MichaelForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 14, 2023-$500KRXRXSEC Form 4 filed by Secora MichaelForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 15, 2023RXRXSEC Form 4 filed by Secora MichaelForm 4Shares withheld for taxes or exercise price
- Feb 4, 2022RXRXSEC Form 4 filed by Secora Michael (Amendment)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 15, 2023RXRXSEC Form 4: Secora Michael covered exercise/tax liability with 1,258 shares, decreasing direct ownership by 0.16% to 794,310 units (tax withholding)Form 4Shares withheld for taxes or exercise price
- Feb 1, 2023RXRXSEC Form 4: Secora Michael was granted 210,163 shares and covered exercise/tax liability with 2,669 shares, increasing direct ownership by 35% to 795,568 units (tax withholding)Form 4Grant or awardShares withheld for taxes or exercise price
- Nov 15, 2022RXRXSEC Form 4: Secora Michael covered exercise/tax liability with 1,065 shares, decreasing direct ownership by 0.18% to 586,572 units to cover withholding taxForm 4Shares withheld for taxes or exercise price
- Aug 15, 2022RXRXSEC Form 4: Secora Michael covered exercise/tax liability with 1,065 shares, decreasing direct ownership by 0.18% to 587,637 units to satisfy tax liabilityForm 4Shares withheld for taxes or exercise price
- May 16, 2022RXRXSEC Form 4: Secora Michael covered exercise/tax liability with 1,069 shares, decreasing direct ownership by 0.18% to 588,702 unitsForm 4Shares withheld for taxes or exercise price10b5-1 plan
- Feb 4, 2022RXRXSEC Form 4: Secora Michael was granted 60,299 shares and covered exercise/tax liability with 678 shares, increasing direct ownership by 11% to 589,771 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Apr 20, 2021RXRXSEC Form 4: Secora Michael converted 149,077 units into Common Stock, increasing direct ownership by 39% to 528,762 unitsForm 4Conversion of a derivativeOther acquisition or disposition
Compare Michael Secora with
- Michael Secora vs Fred Hassan1 shared
- Michael Secora vs Blake Borgeson1 shared
- Michael Secora vs Zavain Dar1 shared
- Michael Secora vs Dean Y Li1 shared
- Michael Secora vs Ben R Taylor1 shared
- Michael Secora vs Najat Khan1 shared
Other insiders at the same companies
- Fred HassanRXRX
- Blake BorgesonRXRX
- Zavain DarRXRX
- Dean Y LiRXRX
- Ben R TaylorRXRX
- Najat KhanRXRX
- David HallettRXRX
- Robert HershbergRXRX
- Franziska MichorRXRX
- Elaine D SunRXRX
- Namandje BumpusRXRX
- Christopher GibsonRXRX
- David J MauroRXRX
- Tina MarriottRXRX
Questions about Michael Secora
- What is Michael Secora's role at Recursion Pharmaceuticals, Inc.?
- Michael Secora reports to the SEC as chief Financial Officer at Recursion Pharmaceuticals, Inc. (RXRX), according to the latest filing on November 19, 2024.
- How many shares does Michael Secora own?
- After the latest filing that states it, Michael Secora directly owned 1,487,694 shares of Recursion Pharmaceuticals, Inc. (RXRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Secora bought or sold stock recently?
- The most recent open-market sale was on November 13, 2024: sold 30,000 shares of Recursion Pharmaceuticals, Inc. (RXRX) for $230K at an average of $7.65.
- How do I get alerts when Michael Secora files?
- Follow Michael Secora on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Secora (SEC CIK 0001855980). Totals count each trade once, skipping amendments whose original is on file, from Apr 23, 2021 on. View on SEC EDGAR